- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Denosumab – July 2016
Denosumab: 60 mg/mL injection, 1 × 1 mL syringe, Prolia®
Last updated
28 October 2016